Company intelligence / Profile preview

MTI

Ames, Iowa, United Statesmtishows.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

MTI Biotech’s primary innovation is the discovery and development of beta-hydroxy beta-methylbutyrate (HMB), which has undergone extensive preclinical and clinical testing for safety and efficacy. The company focuses on research-backed nutritional ingredients with strong scientific evidence supporting their use

Therapeutic areas: Other
Modalities: Small moleculeNutritional supplement (nutraceutical)
Industry: Food & Nutrition

Partnerships

Heartland Assays LLC – strategic partnership for analytical services

Beyond the preview

Go deeper on MTI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTI.

Explore the full profile